region system distribut anti-tumor heteroaggreg antibodi human peripher blood lymphocyt human colon cancer xenograft anti-tumor antibodi antibodi heteroaggreg HA antibodi pbl tumor cell appropri tumor Ag i.v i.p distribut radiolabel HA antibodi cultur human pbl athym nude mice solid intraperiton tumor human colon tumor line mice HA antibodi anti-tumor mab pbl design timepoint tissu radioact site tumor radioact level percent dose/gram HA antibodi anti-tumor mab similar level anti-tumor mab major differ radioact level i.v i.p administr increas hepat radioact i.v HA antibodi administr HA antibodi fragment decreas Fc receptor-medi bind improv tumor tissu ratio antibodi HA antibodi level equival HA antibodi level tumor intact HA antibodi level blood bowel tumor bowel ratio i.p autoradiographi anti-tumor HA antibodi tumor i.p HA antibodi tumor i.v HA antibodi tumor vasculatur cultur human pbl moder concentr tumor i.v poor local i.v pbl speci dispar receptor endotheli ligand problem syngen model result region therapi HA antibodi pbl advantag system therapi initi clinic trial 